Drug Profile
D4E1
Latest Information Update: 25 Feb 2008
Price :
$50
*
At a glance
- Originator Demegen
- Class Antibacterials; Peptide antibiotics; Peptides
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Mycoses; Respiratory tract infections; Viral infections
Most Recent Events
- 27 Jun 2003 Suspended - Preclinical for Bacterial infections in USA (unspecified route)
- 27 Jun 2003 Suspended - Preclinical for Mycoses in USA (unspecified route)
- 27 Jun 2003 Suspended - Preclinical for Respiratory tract infections in USA (unspecified route)